Your browser doesn't support javascript.
loading
Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer.
Kwon, Hyunwoo; Schafer, Johanna M; Song, No-Joon; Kaneko, Satoshi; Li, Anqi; Xiao, Tong; Ma, Anjun; Allen, Carter; Das, Komal; Zhou, Lei; Riesenberg, Brian; Chang, Yuzhou; Weltge, Payton; Velegraki, Maria; Oh, David Y; Fong, Lawrence; Ma, Qin; Sundi, Debasish; Chung, Dongjun; Li, Xue; Li, Zihai.
Afiliação
  • Kwon H; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Schafer JM; Medical Scientist Training Program, College of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
  • Song NJ; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Kaneko S; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Li A; Department of Urology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Xiao T; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Ma A; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Allen C; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Das K; Department of Biomedical Informatics, Ohio State University, Columbus, OH 43210, USA.
  • Zhou L; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Riesenberg B; Department of Biomedical Informatics, Ohio State University, Columbus, OH 43210, USA.
  • Chang Y; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Weltge P; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Velegraki M; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Oh DY; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Fong L; Department of Biomedical Informatics, Ohio State University, Columbus, OH 43210, USA.
  • Ma Q; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Sundi D; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer Center-James, Columbus, OH 43210, USA.
  • Chung D; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Li X; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Li Z; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94143, USA.
Sci Immunol ; 7(73): eabq2630, 2022 07.
Article em En | MEDLINE | ID: mdl-35420889
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos